These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 11261760)
21. [A case of pulmonary Mycobacterium kansasii infection with pleural effusion, distinguished from pulmonary tuberculosis]. Kimura Y; Kurosawa T; Hosaka K Kekkaku; 2014 Sep; 89(9):737-41. PubMed ID: 25730945 [TBL] [Abstract][Full Text] [Related]
22. AIDS-related Mycobacterium kansasii infection with initial resistance to clarithromycin. Burman WJ; Stone BL; Brown BA; Wallace RJ; Böttger EC Diagn Microbiol Infect Dis; 1998 Jun; 31(2):369-71. PubMed ID: 9635911 [TBL] [Abstract][Full Text] [Related]
23. Presumed choroidal atypical tuberculosis superinfected with cytomegalovirus retinitis in an acquired immunodeficiency syndrome patient: a case report. Lai LJ; Chen SN; Kuo YH; Ho JD; Ho CL Jpn J Ophthalmol; 2002; 46(4):463-8. PubMed ID: 12225828 [TBL] [Abstract][Full Text] [Related]
24. Coexistence of oligo-articular gout and Mycobacterium kansasii joint and bursal infection in a patient with an orthotopic heart transplant. Baker JF; Stonecypher M Clin Exp Rheumatol; 2009; 27(5):843-5. PubMed ID: 19917172 [TBL] [Abstract][Full Text] [Related]
25. [Mycobacterium kansasii infection in chronic thromboembolic pulmonary hypertension (CTEPH), report of two cases]. Szturmowicz M; Fijałkowska A; Rowińska-Zakrzewska E; Khalil LY; Piwek A; Kuca P; Opoka L; Augustynowicz-Kopeć E; Zwolska Z; Torbicki A Pneumonol Alergol Pol; 2004; 72(11-12):523-9. PubMed ID: 16329355 [TBL] [Abstract][Full Text] [Related]
26. Mycobacterium kansasii Infection in a Patient Receiving Biologic Therapy-Not All Reactive Interferon Gamma Release Assays Are Tuberculosis. Saleem N; Saba R; Maddika S; Weinstein M Am J Med Sci; 2017 Apr; 353(4):394-397. PubMed ID: 28317629 [TBL] [Abstract][Full Text] [Related]
27. Cutaneous infection with Mycobacterium kansasii in a patient with myelodysplastic syndrome and Sweet syndrome. Sprague J; Leibowitz M; Chiu MW Cutis; 2015 Jul; 96(1):E10-2. PubMed ID: 26244358 [No Abstract] [Full Text] [Related]
28. Mycobacterium kansasii: a cause of treatable pulmonary disease associated with advanced human immunodeficiency virus (HIV) infection. Levine B; Chaisson RE Ann Intern Med; 1991 May; 114(10):861-8. PubMed ID: 1673053 [TBL] [Abstract][Full Text] [Related]
30. Temporal interferon-gamma release response to Mycobacterium kansasii infection in an anorexia nervosa patient. Cosson MA; Bertrand JB; Martin C; Veziris N; Picard C; Goulvestre C; Coignard S; Benoit JP; Silvera S; Moro MR; Poyart C; Morand PC J Med Microbiol; 2012 Nov; 61(Pt 11):1617-1620. PubMed ID: 22859583 [TBL] [Abstract][Full Text] [Related]
31. Mortality prediction in pulmonary Mycobacterium kansasii infection and human immunodeficiency virus. Marras TK; Morris A; Gonzalez LC; Daley CL Am J Respir Crit Care Med; 2004 Oct; 170(7):793-8. PubMed ID: 15215152 [TBL] [Abstract][Full Text] [Related]
32. Clinical and radiological features of Mycobacterium kansasii and other NTM infections. Matveychuk A; Fuks L; Priess R; Hahim I; Shitrit D Respir Med; 2012 Oct; 106(10):1472-7. PubMed ID: 22850110 [TBL] [Abstract][Full Text] [Related]
33. Pulmonary Padmapriyadarsini C; Nair D; Gomathi NS; Velayudham B Indian J Med Microbiol; 2016; 34(4):516-519. PubMed ID: 27934834 [TBL] [Abstract][Full Text] [Related]
34. An AIDS patient with immune reconstitution inflammatory syndrome due to pulmonary Mycobacterium kansasii infection during antiretroviral therapy. Ito M; Komatsu Y; Ushiki A; Yamazaki Y; Kubo K J Infect Chemother; 2009 Oct; 15(5):331-4. PubMed ID: 19856074 [TBL] [Abstract][Full Text] [Related]
35. Clinical and radiographic manifestations of uncommon pulmonary nontuberculous mycobacterial disease in AIDS patients. El-Solh AA; Nopper J; Abdul-Khoudoud MR; Sherif SM; Aquilina AT; Grant BJ Chest; 1998 Jul; 114(1):138-45. PubMed ID: 9674460 [TBL] [Abstract][Full Text] [Related]
36. [Swelling of right knee in an immunologically compromised patient]. Cajigas-Pezo D; Lorenzo-Hernandez A; Vives-Rivero GR; Rentero-Martínez Z Enferm Infecc Microbiol Clin; 2012 Oct; 30(8):481-2. PubMed ID: 22521279 [No Abstract] [Full Text] [Related]
37. Clinical manifestations and implications of coinfection with Mycobacterium kansasii and human immunodeficiency virus type 1. Witzig RS; Fazal BA; Mera RM; Mushatt DM; Dejace PM; Greer DL; Hyslop NE Clin Infect Dis; 1995 Jul; 21(1):77-85. PubMed ID: 7578764 [TBL] [Abstract][Full Text] [Related]
38. Mycobacterium kansasii: its presentation, treatment and outcome in HIV infected patients. Rooney G; Nelson MR; Gazzard B J Clin Pathol; 1996 Oct; 49(10):821-3. PubMed ID: 8943748 [TBL] [Abstract][Full Text] [Related]
39. Detailed analysis of the radiographic presentation of Mycobacterium kansasii lung disease in patients with HIV infection. Cattamanchi A; Nahid P; Marras TK; Gotway MB; Lee TJ; Gonzalez LC; Morris A; Webb WR; Osmond DH; Daley CL Chest; 2008 Apr; 133(4):875-80. PubMed ID: 18263685 [TBL] [Abstract][Full Text] [Related]
40. [Clinical analysis of 96 cases with pulmonary disease caused by nontuberculous mycobacteria]. Xia X; Gui X Zhonghua Jie He He Hu Xi Za Zhi; 1999 Apr; 22(4):239-41. PubMed ID: 11775923 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]